+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Autoimmune Disease Diagnostics Market By Type (Systemic, Organ-Specific), By Sex (Male, Female), By Age, By Factors (Diet, Genetics, Environmental agents), By Diagnosis, By Types of Treatment, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025

  • PDF Icon

    Report

  • May 2020
  • Region: Global
  • TechSci Research
  • ID: 5022636
UP TO OFF until Dec 31st 2022
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Autoimmune Disease Diagnostics Market size was valued at USD4 billion in 2019 and projected to grow at a formidable CAGR during the forecast period. The key factor driving the growth of autoimmune disease diagnostics market is surging investment in the healthcare sector. Additionally, growing cases of autoimmune diseases is further anticipated to bode well for the growth of autoimmune disease diagnostics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is projected to bolster the market growth through 2025. Moreover, growing implementation of lab automation technologies in developing nations such as U.S. and Europe are further aiding the market growth.

The Global Autoimmune Disease Diagnostics Market is segmented based on type, sex, age, factors, diagnosis, types of treatment, product, end-user, region and company. Based on product, the market can be segmented into kits and assays, reagents and instruments. Out of which, the kits and assays segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to increasing adoption of kits and assays in hospitals and clinical laboratories. Moreover, increasing prevalence of autoimmune diseases coupled with growing requirement for fast results, is expected to boost the growth of the segment in the upcoming years.

Major players operating in the autoimmune disease diagnostics market include Siemens, Abbott, Bio-Rad Laboratories, Pfizer, Johnson and Johnson, Grifols, Trinity Biotech, Thermo Fisher Scientific, Inova Diagnostics, Hycor Biomedical, Euroimmun, Protagen, Roche, Quest Diagnostics, Hemagen Diagnostics, Aesku Diagnostics, Sanofi, Sun Pharmaceutical Industries Ltd., Eli Lilly, Bayer, etc. The companies operating in autoimmune disease diagnostics market across the globe are focussing more towards the expanding their share in the market. For instance, these key players are making organic strategies such as mergers and acquisitions, among others in order to survive the highly competitive industry.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025

Objective of the Study:
  • To analyse and forecast the market size of the Global Autoimmune Disease Diagnostics Market.
  • To classify and forecast the Global Autoimmune Disease Diagnostics Market based on type, sex, age, factors, diagnosis, types of treatment, product, end-user, company and regional distribution.
  • To identify drivers and challenges for the Global Autoimmune Disease Diagnostics Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Autoimmune Disease Diagnostics Market.
  • To conduct pricing analysis for the Global Autoimmune Disease Diagnostics Market.
  • To identify and analyse the profile of leading players operating in the Global Autoimmune Disease Diagnostics Market.

The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of companies across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the companies which could not be identified due to the limitations of secondary research. The author analyzed the new products, distribution channels and presence of all major players across the globe.

The author calculated the market size of the Global Autoimmune Disease Diagnostics Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Autoimmune disease diagnostics companies and other stakeholders.
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to autoimmune disease diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Autoimmune Disease Diagnostics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Type:
  • Systemic
  • Organ-specific

Market, By Sex:
  • Male
  • Female

Market, By Age:
  • 0-15
  • 15-44
  • 44+

Market, By Factors:
  • Diet
  • Genetics
  • Environmental Agents

Market, By Diagnosis:
  • Antinuclear Antibody Test
  • Autoantibody Test
  • CBC
  • Comprehensive Metabolic Panel
  • C-reactive Protein
  • Erythrocyte Sedimentation Rate
  • Urinalysis
  • Imaging Test
  • Biopsy

Market, By Types of Treatment:
  • Nonsteroidal Anti-Inflammatory Drugs
  • Immune-Suppressing Drugs
  • Hormone Replacement Therapy
  • Physical Therapy
  • Blood Transfusion
  • Plasma Exchange
  • Others

Market, By Product:
  • Kits and Assays
  • Reagents
  • Instruments

Market, By End-User:
  • Hospital
  • Clinics
  • Diagnostic Laboratories
  • Others

Market, By Region:
  • North America
  • United States
  • Mexico
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Autoimmune Disease Diagnostics Market.

Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.

Table of Contents

1. Product Overview2. Research Methodology3. Executive Summary
4. Global Autoimmune Disease Diagnostics Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value & Volume
4.2. Market Share & Forecast
4.2.1. By Type (Systemic, Organ-specific (Localized))
4.2.2. By Sex (Male, Female)
4.2.3. By Age (0-15, 15-44, 44+)
4.2.4. By Factors (Diet, Genetics, Environmental agents)
4.2.5. By Diagnosis (Antinuclear antibody test (ANR), Autoantibody test, CBC (Complete Blood Count), Comprehensive Metabolic Panel, C-reactive protein (CRP), Erythrocyte sedimentation rate (ESR), Urinalysis, Imaging test, Biopsy)
4.2.6. By Types of Treatment (Nonsteroidal anti-inflammatory drugs (NSAIDs), Immune-suppressing drugs, Hormone replacement therapy, Physical therapy, Blood transfusion, Plasma Exchange, Others)
4.2.7. By Product (Kits and assays, Reagents, Instruments)
4.2.8. By End-User (Hospital, Clinics, Diagnostic laboratories, Others)
4.2.9. By Company (2019)
4.2.10. By Region
4.3. Market Attractiveness Index
5. Asia-Pacific Autoimmune Disease Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Type
5.2.2. By Sex
5.2.3. By Age
5.2.4. By Factors
5.2.5. By Diagnosis
5.2.6. By Types of Treatment
5.2.7. By Product
5.2.8. By End-User
5.2.9. By Country
5.3. Market Attractiveness Index
5.4. Asia-Pacific: Country Analysis
5.4.1. China Autoimmune Disease Diagnostics Market Outlook
5.4.1.1. Market Size & Forecast
5.4.1.1.1. By Value
5.4.1.2. Market Share & Forecast
5.4.1.2.1. By Type
5.4.1.2.2. By Sex
5.4.1.2.3. By Age
5.4.1.2.4. By Factors
5.4.1.2.5. By Diagnosis
5.4.1.2.6. By Types of Treatment
5.4.1.2.7. By Product
5.4.1.2.8. By End-User
5.4.2. India Autoimmune Disease Diagnostics Market Outlook
5.4.2.1. Market Size & Forecast
5.4.2.1.1. By Value
5.4.2.2. Market Share & Forecast
5.4.2.2.1. By Type
5.4.2.2.2. By Sex
5.4.2.2.3. By Age
5.4.2.2.4. By Factors
5.4.2.2.5. By Diagnosis
5.4.2.2.6. By Types of Treatment
5.4.2.2.7. By Product
5.4.2.2.8. By End-User
5.4.3. Japan Autoimmune Disease Diagnostics Market Outlook
5.4.3.1. Market Size & Forecast
5.4.3.1.1. By Value
5.4.3.2. Market Share & Forecast
5.4.3.2.1. By Type
5.4.3.2.2. By Sex
5.4.3.2.3. By Age
5.4.3.2.4. By Factors
5.4.3.2.5. By Diagnosis
5.4.3.2.6. By Types of Treatment
5.4.3.2.7. By Product
5.4.3.2.8. By End-User
5.4.4. South Korea Autoimmune Disease Diagnostics Market Outlook
5.4.4.1. Market Size & Forecast
5.4.4.1.1. By Value
5.4.4.2. Market Share & Forecast
5.4.4.2.1. By Type
5.4.4.2.2. By Sex
5.4.4.2.3. By Age
5.4.4.2.4. By Factors
5.4.4.2.5. By Diagnosis
5.4.4.2.6. By Types of Treatment
5.4.4.2.7. By Product
5.4.4.2.8. By End-User
5.4.5. Singapore Autoimmune Disease Diagnostics Market Outlook
5.4.5.1. Market Size & Forecast
5.4.5.1.1. By Value
5.4.5.2. Market Share & Forecast
5.4.5.2.1. By Type
5.4.5.2.2. By Sex
5.4.5.2.3. By Age
5.4.5.2.4. By Factors
5.4.5.2.5. By Diagnosis
5.4.5.2.6. By Types of Treatment
5.4.5.2.7. By Product
5.4.5.2.8. By End-User
5.4.6. Australia Autoimmune Disease Diagnostics Market Outlook
5.4.6.1. Market Size & Forecast
5.4.6.1.1. By Value
5.4.6.2. Market Share & Forecast
5.4.6.2.1. By Type
5.4.6.2.2. By Sex
5.4.6.2.3. By Age
5.4.6.2.4. By Factors
5.4.6.2.5. By Diagnosis
5.4.6.2.6. By Types of Treatment
5.4.6.2.7. By Product
5.4.6.2.8. By End-User
6. Europe Autoimmune Disease Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Sex
6.2.3. By Age
6.2.4. By Factors
6.2.5. By Diagnosis
6.2.6. By Types of Treatment
6.2.7. By Product
6.2.8. By End-User
6.2.9. By Country
6.3. Market Attractiveness Index
6.4. Europe: Country Analysis
6.4.1. France Autoimmune Disease Diagnostics Market Outlook
6.4.1.1. Market Size & Forecast
6.4.1.1.1. By Value
6.4.1.2. Market Share & Forecast
6.4.1.2.1. By Type
6.4.1.2.2. By Sex
6.4.1.2.3. By Age
6.4.1.2.4. By Factors
6.4.1.2.5. By Diagnosis
6.4.1.2.6. By Types of Treatment
6.4.1.2.7. By Product
6.4.1.2.8. By End-User
6.4.2. Germany Autoimmune Disease Diagnostics Market Outlook
6.4.2.1. Market Size & Forecast
6.4.2.1.1. By Value
6.4.2.2. Market Share & Forecast
6.4.2.2.1. By Type
6.4.2.2.2. By Sex
6.4.2.2.3. By Age
6.4.2.2.4. By Factors
6.4.2.2.5. By Diagnosis
6.4.2.2.6. By Types of Treatment
6.4.2.2.7. By Product
6.4.2.2.8. By End-User
6.4.3. United Kingdom Autoimmune Disease Diagnostics Market Outlook
6.4.3.1. Market Size & Forecast
6.4.3.1.1. By Value
6.4.3.2. Market Share & Forecast
6.4.3.2.1. By Type
6.4.3.2.2. By Sex
6.4.3.2.3. By Age
6.4.3.2.4. By Factors
6.4.3.2.5. By Diagnosis
6.4.3.2.6. By Types of Treatment
6.4.3.2.7. By Product
6.4.3.2.8. By End-User
6.4.4. Italy Autoimmune Disease Diagnostics Market Outlook
6.4.4.1. Market Size & Forecast
6.4.4.1.1. By Value
6.4.4.2. Market Share & Forecast
6.4.4.2.1. By Type
6.4.4.2.2. By Sex
6.4.4.2.3. By Age
6.4.4.2.4. By Factors
6.4.4.2.5. By Diagnosis
6.4.4.2.6. By Types of Treatment
6.4.4.2.7. By Product
6.4.4.2.8. By End-User
6.4.5. Spain Autoimmune Disease Diagnostics Market Outlook
6.4.5.1. Market Size & Forecast
6.4.5.1.1. By Value
6.4.5.2. Market Share & Forecast
6.4.5.2.1. By Type
6.4.5.2.2. By Sex
6.4.5.2.3. By Age
6.4.5.2.4. By Factors
6.4.5.2.5. By Diagnosis
6.4.5.2.6. By Types of Treatment
6.4.5.2.7. By Product
6.4.5.2.8. By End-User
6.4.5.2.9.
7. North America Autoimmune Disease Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Sex
7.2.3. By Age
7.2.4. By Factors
7.2.5. By Diagnosis
7.2.6. By Types of Treatment
7.2.7. By Product
7.2.8. By End-User
7.2.9. By Country
7.3. Market Attractiveness Index
7.4. North America: Country Analysis
7.4.1. United States Autoimmune Disease Diagnostics Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Type
7.4.1.2.2. By Sex
7.4.1.2.3. By Age
7.4.1.2.4. By Factors
7.4.1.2.5. By Diagnosis
7.4.1.2.6. By Types of Treatment
7.4.1.2.7. By Product
7.4.1.2.8. By End-User
7.4.2. Mexico Autoimmune Disease Diagnostics Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Type
7.4.2.2.2. By Sex
7.4.2.2.3. By Age
7.4.2.2.4. By Factors
7.4.2.2.5. By Diagnosis
7.4.2.2.6. By Types of Treatment
7.4.2.2.7. By Product
7.4.2.2.8. By End-User
7.4.3. Canada Autoimmune Disease Diagnostics Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Type
7.4.3.2.2. By Sex
7.4.3.2.3. By Age
7.4.3.2.4. By Factors
7.4.3.2.5. By Diagnosis
7.4.3.2.6. By Types of Treatment
7.4.3.2.7. By Product
7.4.3.2.8. By End-User
8. South America Autoimmune Disease Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Sex
8.2.3. By Age
8.2.4. By Factors
8.2.5. By Diagnosis
8.2.6. By Types of Treatment
8.2.7. By Product
8.2.8. By End-User
8.2.9. By Country
8.3. Market Attractiveness Index
8.4. South America: Country Analysis
8.4.1. Brazil Autoimmune Disease Diagnostics Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Type
8.4.1.2.2. By Sex
8.4.1.2.3. By Age
8.4.1.2.4. By Factors
8.4.1.2.5. By Diagnosis
8.4.1.2.6. By Types of Treatment
8.4.1.2.7. By Product
8.4.1.2.8. By End-User
8.4.2. Argentina Autoimmune Disease Diagnostics Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Type
8.4.2.2.2. By Sex
8.4.2.2.3. By Age
8.4.2.2.4. By Factors
8.4.2.2.5. By Diagnosis
8.4.2.2.6. By Types of Treatment
8.4.2.2.7. By Product
8.4.2.2.8. By End-User
8.4.3. Colombia Autoimmune Disease Diagnostics Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Type
8.4.3.2.2. By Sex
8.4.3.2.3. By Age
8.4.3.2.4. By Factors
8.4.3.2.5. By Diagnosis
8.4.3.2.6. By Types of Treatment
8.4.3.2.7. By Product
8.4.3.2.8. By End-User
9. Middle East and Africa Autoimmune Disease Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Sex
9.2.3. By Age
9.2.4. By Factors
9.2.5. By Diagnosis
9.2.6. By Types of Treatment
9.2.7. By Product
9.2.8. By End-User
9.2.9. By Country
9.3. Market Attractiveness Index
9.4. MEA: Country Analysis
9.4.1. South Africa Autoimmune Disease Diagnostics Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Type
9.4.1.2.2. By Sex
9.4.1.2.3. By Age
9.4.1.2.4. By Factors
9.4.1.2.5. By Diagnosis
9.4.1.2.6. By Types of Treatment
9.4.1.2.7. By Product
9.4.1.2.8. By End-User
9.4.2. Saudi Arabia Autoimmune Disease Diagnostics Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Type
9.4.2.2.2. By Sex
9.4.2.2.3. By Age
9.4.2.2.4. By Factors
9.4.2.2.5. By Diagnosis
9.4.2.2.6. By Types of Treatment
9.4.2.2.7. By Product
9.4.2.2.8. By End-User
9.4.3. UAE Autoimmune Disease Diagnostics Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Type
9.4.3.2.2. By Sex
9.4.3.2.3. By Age
9.4.3.2.4. By Factors
9.4.3.2.5. By Diagnosis
9.4.3.2.6. By Types of Treatment
9.4.3.2.7. By Product
9.4.3.2.8. By End-User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Competitive Landscape
12.1. Competition Outlook
12.2. Players Profiled (Leading Companies)
12.2.1. Siemens
12.2.2. Abbott
12.2.3. Bio-Rad Laboratories
12.2.4. Pfizer
12.2.5. Johnson and Johnson
12.2.6. Grifols
12.2.7. Trinity Biotech
12.2.8. Thermo Fisher Scientific
12.2.9. Inova Diagnostics
12.2.10. Hycor Biomedical
12.2.11. Euroimmun
12.2.12. Protagen
12.2.13. Roche
12.2.14. Quest Diagnostics
12.2.15. Hemagen Diagnostics
12.2.16. Aesku Diagnostics
12.2.17. Sanofi
12.2.18. Sun Pharmaceutical Industries Ltd.
12.2.19. Eli Lilly
12.2.20. Bayer
13. Strategic Recommendations14. About Us & Disclaimer

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Siemens
  • Abbott
  • Bio-Rad Laboratories
  • Pfizer
  • Johnson and Johnson
  • Grifols
  • Trinity Biotech
  • Thermo Fisher Scientific
  • Inova Diagnostics
  • Hycor Biomedical
  • Euroimmun
  • Protagen
  • Roche
  • Quest Diagnostics
  • Hemagen Diagnostics
  • Aesku Diagnostics
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Eli Lilly
  • Bayer